Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-25 @ 9:44 PM
Study NCT ID:
NCT05540951
Status:
UNKNOWN
Last Update Posted:
2022-09-15
First Post:
2022-09-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-12
First Submit QC Date:
None
Study First Post Date:
2022-09-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-14
Last Update Post Date:
2022-09-15
Last Update Post Date Type:
ACTUAL